Podcasts

• Podcast
• Open to all

In the ninth episode of this podcast series, Ana Lemmo Charnalia, Senior Business Manager at UCLB, is in conversation with Orla O’Donnell , Divisional Manager at the UCL Div of Biosciences and former Chief Operating Officer of HeLP Digital CIC, a Community Interest Company incorporated in 2015 to commercialise HeLP-Diabetes. It is also an opportunity to celebrate Professor Elizabeth Murray’s life, who led in the development of HeLP-Diabetes. Join them in this discussion about their experiences and learnings from an early-stage social venture to the national roll-out of an online programme for people with type 2 diabetes.

• Podcast
• Open to all

Over a 15 year journey, UCLB spinout company Senceive Ltd became the world leader in the design, manufacture and supply of wireless enabled remote condition monitoring solutions for use in rail and construction applications. Recognition of the innovative and scalable nature of Senceive’s solutions to keep people and critical infrastructure safe, led to the company being acquired by Eddyfi in April 2021. In this podcast, Senceive’s now retired CEO Graham Smith and Dr Steven Schooling from UCLB discuss their experiences and learnings as they turned an early-stage university spinout into a highly successful and profitable commercial enterprise, which at exit generated strong returns for all shareholders.

• Podcast
• Open to all

In the seventh episode of this podcast series, Jessica Bolton-Murray, Head of Project Management at UCLB, is in conversation with Tanel Ozdemir, Investment Manager for the UCL Technology Fund.

• Podcast
• Open to all

In the sixth episode of this podcast series, UCLB’s Director of BioPharm, Dr Richard Fagan, is in conversation with Dr Chris Williams. Dr Williams is formerly a Senior Business Manager at UCLB; he is now the SVP, Corporate Development at Autolus. Chris was part of the team that founded Autolus in 2014. Autolus, as a company, is focused on the development of engineered CAR T cell therapies, which has been transformational for patients, particularly in blood cancers.

• Podcast

UCLB CEO Dr Anne Lane appeared on the AUTM On The Air podcast to share her thoughts on the power of collaboration between universities, private, and public organisations, and how TenU (which she previously chaired) has helped foster international collaboration and innovation.

• Podcast
• Open to all

In the fifth episode of this podcast series, Marina Santilli, UCLB Associate Director, Engineering & Physical Sciences is in conversation with Dr. Daniel Hulme, CEO and Founder of Satalia. Satalia was UCL’s very first AI spinout company which is now part of the WPP Group of global companies.

• Podcast
• Open to all

In the fourth episode of this podcast series, UCLB’s Director of Engineering and Physical Sciences, Dr Steven Schooling, is in conversation with Marina Santilli, UCLB Associate Director, Engineering & Physical Sciences about the development and scaling of UCLB’s express licensing platform e-lucid. 

• Podcast
• Open to all

In the third episode of this podcast series, UCLB Director of BioPharm, Dr Richard Fagan, is in conversation with the co-founder of UCL spinout Achilles Therapeutics, Professor Charles Swanton. They discuss Achilles Tx’s achievements and how TRACERx, the first study to track the evolution of cancer cells, will help us beat cancer.

• Podcast
• Open to all

In the second episode of this podcast series, UCLB Senior Business Manager, Dr Mark Harding, explores UCL spinout Carbon Re’s journey to market and their impact on reducing carbon emissions in heavy industries. He is joined by the co-founder and Chief Technology Officer of Carbon Re, Professor Aidan O’Sullivan.

• Podcast
• Open to all

In the very first podcast episode, Dr Anne Lane, CEO of UCL Business (UCLB), speaks to Professor Geraint Rees, Vice-Provost of UCL (Research, Innovation & Global Engagement) about what UCLB does, its unique role in UCL, and their future plans to help UCL academics create impact across society.